Lancet Infectious Diseases: HIV drug resistance in naive individuals in sub-Saharan Africa
Audio Controls
Play | Pause | Back 5 seconds | Forward 5 seconds | Go to min.: sec.: | Download | Help
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
Hamers RL et al, Lancet Infectious Diseases 2011, 11; 10: 750-759.
Background:
There are few data on the epidemiology of primary HIV-1 drug resistance after the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the prevalence of primary resistance in six African countries after ART roll-out and if wider use of ART in sub-Saharan Africa is associated with rising prevalence of drug resistance.
Interpretation:
The higher prevalence of primary drug resistance in Uganda than in other African countries is probably related to the earlier start of ART roll-out in Uganda. Resistance surveillance and prevention should be prioritised in settings where ART programmes are scaled up.
Hamers RL et al, Lancet Infectious Diseases 2011, 11; 10: 750-759.
Background:
There are few data on the epidemiology of primary HIV-1 drug resistance after the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the prevalence of primary resistance in six African countries after ART roll-out and if wider use of ART in sub-Saharan Africa is associated with rising prevalence of drug resistance.
Interpretation:
The higher prevalence of primary drug resistance in Uganda than in other African countries is probably related to the earlier start of ART roll-out in Uganda. Resistance surveillance and prevention should be prioritised in settings where ART programmes are scaled up.
Date: 27-09-2011 18:36:31
File mp3 Submitted by : mingha africa onlus
(Go to channel mingha africa onlus »)
Topics: Health, Illness
Geographic zone: Africa
Keywords: HIV, ARV, ART, naive, resistance, study
Length: 00:02:46
This audio has been requested 37 times
